Technical Analysis for IDNA - iShares Genomics Immunology and Healthcare ETF
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 23.86 | 2.18% | 0.51 |
IDNA closed up 2.18 percent on Friday, May 3, 2024, on 78 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Gapped Up | Strength | 2.18% | |
| Outside Day | Range Expansion | 3.57% |
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | 3 days ago |
| Up 2% | 3 days ago |
| Gapped Up (Full) | 3 days ago |
| Rose Above Previous Day's High | 3 days ago |
| Rose Above Upper Bollinger Band | 3 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Keywords: Exchange Traded Fund Immunology Genomics
Classification
Keywords: Exchange Traded Fund Immunology Genomics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.2557 |
| 52 Week Low | 17.2113 |
| Average Volume | 33,637 |
| 200-Day Moving Average | 21.88 |
| 50-Day Moving Average | 23.47 |
| 20-Day Moving Average | 22.62 |
| 10-Day Moving Average | 22.64 |
| Average True Range | 0.46 |
| RSI (14) | 62.55 |
| ADX | 19.23 |
| +DI | 36.50 |
| -DI | 19.84 |
| Chandelier Exit (Long, 3 ATRs) | 22.61 |
| Chandelier Exit (Short, 3 ATRs) | 22.91 |
| Upper Bollinger Bands | 23.82 |
| Lower Bollinger Band | 21.41 |
| Percent B (%b) | 1.02 |
| BandWidth | 10.64 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.26 |
| MACD Histogram | 0.2101 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 24.39 | ||||
| Resistance 3 (R3) | 24.37 | 24.18 | 24.30 | ||
| Resistance 2 (R2) | 24.18 | 24.05 | 24.19 | 24.27 | |
| Resistance 1 (R1) | 24.02 | 23.96 | 24.10 | 24.04 | 24.24 |
| Pivot Point | 23.83 | 23.83 | 23.87 | 23.84 | 23.83 |
| Support 1 (S1) | 23.67 | 23.70 | 23.75 | 23.69 | 23.48 |
| Support 2 (S2) | 23.48 | 23.61 | 23.49 | 23.45 | |
| Support 3 (S3) | 23.32 | 23.48 | 23.42 | ||
| Support 4 (S4) | 23.34 |
